About This Journal:

  • Print This Page
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Journal of Ocular Pharmacology and Therapeutics

Editor-in-Chief: W. Daniel Stamer, PhD

ISSN: 1080-7683 • Online ISSN: 1557-7732 • 10 Issues Annually

Current Volume: 32

Latest Impact Factor* is 1.754

*2015 Journal Citation Reports® published by Thomson Reuters, 2016

Editorial Board

Editor-in-Chief

W. Daniel Stamer, PhD
Duke University
Durham, NC  
 

Associate Editors

Drug Delivery
Uday B. Kompella, PhD
University of Colorado Denver
Denver, CO
 

Retinal Pharmacology
Michael R. Niesman, PhD
MingSight Pharmaceuticals
San Diego, CA

Pre-clinical Ocular Pharmacology
Naj A. Sharif, PhD, FARVO
Santen Incorporated
Emeryville, CA

Ocular Surface Pharmacology
Linda D. Hazlett, PhD
Wayne State University School of Medicine
Detroit, MI

Aqueous Humor Dynamics
Carol B. Toris, PhD
Case Western Reserve University
Cleveland, OH

Editorial Board

Makoto Aihara MD, PhD
University of Tokyo
Tokyo, Japan

Esen K. Akpek, MD
Johns Hopkins University
Baltimore, MD

Michael Allingham, MD, PhD
Duke University
Durham, NC

Curtis R. Brandt, PhD
University of Wisconsin-Madison
Madison, WI

Alain M. Bron, MD 
University Hospital
Dijon, France

  
Abbot Clark, PhD
The University of North Texas Health Science Center 
Fort Worth, TX
 

Craig E. Crosson, PhD
Medical University of South Carolina
Charleston, SC

Nicholas A. Delamere, PhD
University of Arizona
Tucson, AZ

Filippo Drago, MD, PhD
University of Catania Medical School
Catania, Italy

Juana Gallar, MD, PhD
Instituto de Neurociencias UMH-CSIC
San Juan de Alicante, Spain


Jost B. Jonas, MD
Mannheim of the Ruprecht-Karls-University Heidelberg
Mannheim, Germany

Peter F. Kador, PhD
University of Nebraska Medical Center
Omaha, NE 

Jeffrey W. Kiel, PhD
University of Texas Health Science Center at San Antonio
San Antonio, TX      

Achim H. Krauss, PhD
AxeroVision, Inc.
Carlsbad, CA

Hyung Keun Lee, MD
Yonsei University College of Medicine
Seoul, Korea

Goldis Malek, PhD
Duke University
Durham, NC

Alan D. Marmorstein, PhD
Mayo Clinic
Rochester, MN 
 

M. Christine McGahan, PhD
North Carolina State University
Raleigh, NC

Claire H. Mitchell, PhD
University of Pennsylvania
Philadelphia, PA

Ashim K. Mitra, PhD
University of Missouri
Kansas City, MO

Gary D. Novack, PhD
Pharma-Logic Development, Inc.
San Rafael, CA

David E. Potter, PhD
Medical University of South Carolina
Charleston, SC

Ganesh Prasanna, PhD
Novartis Institutes for Biomedical Research (NIBR)
Cambridge, MA

Daniel Saban, PhD
Duke University
Durham, NC 

Leopold Schmetterer, PhD
Singapore Eye Research Institute
Singapore, Singapore

Robert W. Snyder, MD, PhD, PC
University of Arizona
Tucson, AZ

Angela M. Suburo, MD, PhD
Universidad Austral, Pilar
Buenos Aires, Argentina

Khalid F. Tabbara, MD
The Eye Center and The Eye Foundation
   for Research in Ophthalmology
Riyadh, Saudi Arabia

Chi-Ho To, PhD
The Hong Kong Polytechnic University
Kowloon, Hong Kong

Thomas Yorio, PhD
The University of North Texas Health Science Center 
Fort  Worth, TX

Husam S. Younis, PharmD, PhD
NGM Biopharmaceuticals, Inc.
South San Francisco, CA

Oliver Zeitz, MD
Bayer Schering Pharma AG
Berlin, Germany

Founding Editor
George C.Y. Chiou, PhD


Editorial Coordinator

Laura Neuberger
optjournal@verizon.net

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.